Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report
Yingying Huang(Nanfang Hospital), Zhongkang Li, Xueqing Hu(Beijing Hospital), Shuai Zhang(Hebei North University), Yunbo Zhao(University of Science and Technology of China), Xiang‐Yang Wang(Harvard University)
Cited by 2
Related Papers
Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2
|Molecular Cancer|2021|166
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
|Biological Trace Element Research|1997|122
Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer
|Oncotarget|2017|109
CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing
|Proceedings of the National Academy of Sciences|2023|92